These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16490478)

  • 21. Evaluation of the appropriate use of a CIWA-Ar alcohol withdrawal protocol in the general hospital setting.
    Eloma AS; Tucciarone JM; Hayes EM; Bronson BD
    Am J Drug Alcohol Abuse; 2018; 44(4):418-425. PubMed ID: 28981333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-Dose Gabapentin for the Treatment of Severe Alcohol Withdrawal Syndrome: A Retrospective Cohort Analysis.
    Levine AR; Carrasquillo L; Mueller J; Nounou MI; Naut ER; Ibrahim D
    Pharmacotherapy; 2019 Sep; 39(9):881-888. PubMed ID: 31278761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid suppression of alcohol withdrawal syndrome by baclofen.
    Addolorato G; Caputo F; Capristo E; Janiri L; Bernardi M; Agabio R; Colombo G; Gessa GL; Gasbarrini G
    Am J Med; 2002 Feb; 112(3):226-9. PubMed ID: 11893350
    [No Abstract]   [Full Text] [Related]  

  • 24. Baclofen for alcohol withdrawal.
    Liu J; Wang L
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008502. PubMed ID: 21249712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrathecal and oral clonidine as prophylaxis for postoperative alcohol withdrawal syndrome: a randomized double-blinded study.
    Dobrydnjov I; Axelsson K; Berggren L; Samarütel J; Holmström B
    Anesth Analg; 2004 Mar; 98(3):738-44, table of contents. PubMed ID: 14980929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Comparison of Injectable Diazepam and Lorazepam in the Goal-Directed Management of Severe Alcohol Withdrawal.
    Brickel KH; Hodge EK; Zavgorodnyaya D; Schroeder JM; Brown LH; Daley MJ
    Ann Pharmacother; 2024 May; 58(5):453-460. PubMed ID: 37606361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Symptom-Triggered Benzodiazepine Protocol Utilizing SAS and CIWA-Ar Scoring for the Treatment of Alcohol Withdrawal Syndrome in the Critically Ill.
    Sen S; Grgurich P; Tulolo A; Smith-Freedman A; Lei Y; Gray A; Dargin J
    Ann Pharmacother; 2017 Feb; 51(2):101-110. PubMed ID: 27733668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of benzodiazepine-resistant alcohol withdrawal across a healthcare system: Benzodiazepine dose-escalation with or without propofol.
    Wong A; Benedict NJ; Lohr BR; Pizon AF; Kane-Gill SL
    Drug Alcohol Depend; 2015 Sep; 154():296-9. PubMed ID: 26205315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baclofen during alcohol detoxification reduces the need for additional diazepam: a randomized placebo-controlled trial.
    Crunelle CL; Jegham S; Vanderbruggen N; Matthys F
    Alcohol Alcohol; 2023 Sep; 58(5):565-569. PubMed ID: 37526038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baclofen blocks expression and sensitization of anxiety-like behavior in an animal model of repeated stress and ethanol withdrawal.
    Knapp DJ; Overstreet DH; Breese GR
    Alcohol Clin Exp Res; 2007 Apr; 31(4):582-95. PubMed ID: 17374037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Gabapentin and Baclofen Combination for Inpatient Management of Alcohol Withdrawal Syndrome.
    Karapetyan K; Rosenfeldt Z; Caniff K
    Fed Pract; 2023 Apr; 40(4):128-133. PubMed ID: 37223663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
    Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
    Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Acute Alcohol Withdrawal Syndrome in Critically Ill Patients.
    Dixit D; Endicott J; Burry L; Ramos L; Yeung SY; Devabhakthuni S; Chan C; Tobia A; Bulloch MN
    Pharmacotherapy; 2016 Jul; 36(7):797-822. PubMed ID: 27196747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anxiolytic etifoxine protects against convulsant and anxiogenic aspects of the alcohol withdrawal syndrome in mice.
    Verleye M; Heulard I; Gillardin JM
    Alcohol; 2009 May; 43(3):197-206. PubMed ID: 19393860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should the CIWA-Ar be the standard monitoring strategy for alcohol withdrawal syndrome in the intensive care unit?
    Steel TL; Giovanni SP; Katsandres SC; Cohen SM; Stephenson KB; Murray B; Sobeck H; Hough CL; Bradley KA; Williams EC
    Addict Sci Clin Pract; 2021 Mar; 16(1):21. PubMed ID: 33762020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An observational study of benzodiazepine prescription during inpatient alcohol detoxification for patients with vs. without chronic pretreatment with high-dosage baclofen.
    Martinez L; Vorspan F; Declèves X; Azuar J; Fortias M; Questel F; Dereux A; Grichy L; Barreteau H; Bellivier F; Lépine JP; Bloch V
    Fundam Clin Pharmacol; 2018 Apr; 32(2):200-205. PubMed ID: 29224234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Adjunctive Dexmedetomidine in the Treatment of Alcohol Withdrawal Compared to Benzodiazepine Symptom-Triggered Therapy in Critically Ill Patients: The EvADE Study.
    Collier TE; Farrell LB; Killian AD; Kataria VK
    J Pharm Pract; 2022 Jun; 35(3):356-362. PubMed ID: 33297835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study with Grandaxin and diazepam in alcohol withdrawal syndrome and gerontopsychiatric diseases.
    Bánki CM
    Ther Hung; 1983; 31(3):120-5. PubMed ID: 6152821
    [No Abstract]   [Full Text] [Related]  

  • 39. Multidimensionality of the Alcohol Withdrawal Symptom Checklist: a factor analysis of the Alcohol Withdrawal Symptom Checklist and CIWA-Ar.
    Pittman B; Gueorguieva R; Krupitsky E; Rudenko AA; Flannery BA; Krystal JH
    Alcohol Clin Exp Res; 2007 Apr; 31(4):612-8. PubMed ID: 17374040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of GABA(B) receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics.
    Colombo G; Addolorato G; Agabio R; Carai MA; Pibiri F; Serra S; Vacca G; Gessa GL
    Neurotox Res; 2004; 6(5):403-14. PubMed ID: 15545024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.